chr11-44618721-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_002231.4(CD82):c.724G>A(p.Glu242Lys) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000161 in 1,612,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002231.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD82 | NM_002231.4 | c.724G>A | p.Glu242Lys | missense_variant, splice_region_variant | 9/10 | ENST00000227155.9 | NP_002222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD82 | ENST00000227155.9 | c.724G>A | p.Glu242Lys | missense_variant, splice_region_variant | 9/10 | 1 | NM_002231.4 | ENSP00000227155.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249726Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135110
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1460116Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 8AN XY: 726472
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152022Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74242
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 29, 2022 | The c.724G>A (p.E242K) alteration is located in exon 9 (coding exon 7) of the CD82 gene. This alteration results from a G to A substitution at nucleotide position 724, causing the glutamic acid (E) at amino acid position 242 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at